{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/899c4ba1-1eef-5c83-9383-46d0459ab8c9/6aa8d7ef4cef87591dbb05bc?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"the COB: yielding trouble","description":"<p>Our Top 3 Videos</p><p><a href=\"https://ausbiz.com.au/media/is-pixclara-approval-just-the-beginning-for-telix?videoId=51049&amp;utm_campaign=51560240-LongView&amp;utm_source=hs_email&amp;utm_medium=email&amp;_hsenc=p2ANqtz-_wuuQ-WNaqggRMIEDyuqQO9mYiilUmqZt51KAWULICnF_WeUWZzcv31UKt_L0GJV2z0ZwX\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>Clearer picture</strong></a></p><p><a href=\"https://ausbiz.com.au/media/saas-is-back?videoId=51053&amp;utm_campaign=51560240-LongView&amp;utm_source=hs_email&amp;utm_medium=email&amp;_hsenc=p2ANqtz-_wuuQ-WNaqggRMIEDyuqQO9mYiilUmqZt51KAWULICnF_WeUWZzcv31UKt_L0GJV2z0ZwX\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>Back to basics</strong></a></p><p><a href=\"https://ausbiz.com.au/media/the-next-dose-for-healthcare-investors?videoId=51051&amp;utm_campaign=51560240-LongView&amp;utm_source=hs_email&amp;utm_medium=email&amp;_hsenc=p2ANqtz-_wuuQ-WNaqggRMIEDyuqQO9mYiilUmqZt51KAWULICnF_WeUWZzcv31UKt_L0GJV2z0ZwX\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>Worth the weight</strong></a></p>","author_name":"ausbiz"}